Moreover, several recent studies have shown that genetic ablation of Tau and Tau reduction can attenuate autism-like phenotypes in Cntnap2−/− mice and Dravet syndrome model mice (Scn1aRX/+) [7–10]. The gene discussed is MAPT; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.